D-Nav device to be made available in Northern Ireland

The d-Nav device, which allows people to control their insulin dosage in response to their blood glucose levels, is to be made available to diabetes patients in Northern Ireland.
The d-Nav was trialled in June 2014. After a successful trial ru, the d-Nav is to be made available to as many as 700 diabetes patients in Northern Island.
“This new initiative has the potential to be hugely impactful on the lives of many people with diabetes across the world,” said Dr. Roy Harper, who oversaw the d-Nav pilot scheme.
“I am delighted that for the first time in the world, it will now be available to a significant number of patients across the south eastern trust area.”
The d-Nav insulin guidance service uses smart technology and a fingerprint blood test to automatically adjust the insulin dosage of the user, potentially allowing for more precise control over blood glucose levels.
As well as improving the health of diabetes patients throughout Northern Ireland and minimising the risk of complications, the d-Nav could save a huge amount of money. Diabetes care costs the Northern Irish economy £400m a year.
Michael Anyadike-Danes is one of the patients involved in the d-Nav trial. He said: “I have been a diabetic for 20 years but now for the first time, diabetes doesn’t rule my life. I feel better, fitter and above all, normal. I visit the hospital less frequently and the information of my blood glucose and insulin dosage is on the device for my doctor to monitor.”
The d-Nav will not be exclusively available to people with type 1 diabetes. Some people with insulin-dependent type 2 diabetes will also be offered the d-Nav device.